# Phase 1 Study of BPN14770 in Participants With Hepatic Impairment and Healthy Controls

> **NCT07018492** · PHASE1 · COMPLETED · sponsor: **Shionogi** · enrollment: 32 (actual)

## Conditions studied

- Hepatic Impairment

## Interventions

- **DRUG:** BPN14770

## Key facts

- **NCT ID:** NCT07018492
- **Lead sponsor:** Shionogi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-08-30
- **Primary completion:** 2025-11-26
- **Final completion:** 2025-11-26
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2026-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07018492

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07018492, "Phase 1 Study of BPN14770 in Participants With Hepatic Impairment and Healthy Controls". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07018492. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*